spacer
home > epc > Summer 2008
PUBLICATIONS

European Pharmaceutical Contractor

epc
Summer 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in the current issue of EPC.
   
Text
PDF
bullet
Marketplace & Business
Adam Cohen at CHDR discusses the survival of the pharmaceutical industry, drawing on the fate of the dinosaurs for a solution to the increasing numbers of organisations becoming extinct due to a reluctance to adapt to their ever-changing surroundings.  
download pdf
Implementing new technology is invariably a challenge; Charlie Dean of PA Consulting highlights the negative consequences of taking products at face value without considering how they can really benefit your company.  
download pdf
Rapid patient recruitment and cost containment are just two of the factors leading industry and US Government sponsors to view non-traditional regions such as Eastern Europe as preferred locations for pharmaceutical research, claims Paul Wathall of HCA International Ltd.  
download pdf
bullet
Legal & Regulatory
Ethics is as inherent in conducting clinical trials as it is in medicine itself.Gabriela Mergentalova of MSOURCE Medical Development BV looks at how guidelines can be put in place in order to ensure that the appropriate ethical issues are considered and that safety therefore remains the top priority.  
download pdf
Andrzej Zylicz of ComplianceControl considers how, with the expansion of the EU, pharmaceutical life science companies from countries such as Cyprus, Estonia and Poland will face the increasingly complex challenge of developing and implementing compliant solutions that meet EU regulatory requirements.  
download pdf
The Food and Drug Administration Amendments Act of 2007 is arguably the most comprehensive regulatory change to affect pharmaceutical and biotech companies in recent years, and is likely to significantly change how the industry operates. Jeffrey J Stoddard and Edgar H Adams at Covance Periapproval Services consider how to exploit its potential whilst remaining aware of the risks involved.  
download pdf
bullet
Clinical Development
Robert Modre-Osprian and Günter Schreier at Austrian Research Centers GmbH assess the functionality of mobile phones as a means for physicians to track a patient’s personal health status almost irrespective of time and place, helping to increase compliance and reduce challenges for data clearance.  
download pdf
Clinical trial stakeholders are surrounded by data across various desktop spreadsheets, clinical trial management systems and interactive voice response systems; Jaime Cohen of BBK Worldwide investigates in relation to the drive for a patient recruitment strategy.  
download pdf
Liz Moench of MediciGlobal Inc looks at the developing impetus behind paediatric clinical research, purporting that because children are more vulnerable than adults, a sensitive, well thought out approach to patient retention programmes can make a significant contribution to the success of a trial.  
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
Keith Wesnes of Cognitive Drug Research (CDR) examines some of the key issues facing the development of cognition enhancers, looking at the benefits they can have for a variety of mental attributes.  
download pdf
With the development of flow cytometry, central laboratories will most likely be more in demand than ever before. Carol Rosenthal at ICON Central Laboratories and Michael Rosenzweig at Tolerx analyse the details of a technology transfer related to a later phase clinical trial with a view to relocating cytometric assays from the bench.  
download pdf
bullet
LABS & Logistics
Chemical indicators are not supported by regulatory or standards-based guidance for GCCMP and are therefore not appropriate for use in the pharmaceutical industry; electronic temperature indicators should be considered as the most suitable alternative, claims Henry Ames of Sensitech  
download pdf
Natasha Molnár at SCA Cool Logistics contends that it is necessary to consider the sustainability of each individual component of the supply chain in order to improve your efficiency and fully understand the carbon footprint of your temperature-sensitive products  
download pdf
The developments in pharmaceutical labels since the 1930s have been significant, with constant improvements in functionality, versatility and security. Sascha Sonnenberg at Faubel charts the progress made, looking at what the future holds for this sector  
download pdf
bullet
DATA MANAGEMENT
Maximising efficiency and achieving effective long-term cost savings is crucial to ensuring a successful clinical research platform. Dave J Laky of eRT explores the benefits of introducing standards into the clinical research arena, which can positively affect patient safety through more efficient data analysis  
download pdf
The regulatory requirements of electronic submissions, and in particular the electronic common technical document, are rapidly changing; Amanda Keller at Octagon Research Solutions Limited outlines how these developments can improve your chances of meeting agency regulations, as well as optimising operational efficiency.  
download pdf
The pharmaceutical industry has seen a dramatic increase in the number of clinical trials conducted worldwide, which has led many sponsors to rely heavily on the use of electronic data capture (EDC) management and reporting tools to streamline clinical processes.Donna Wooten at Medidata Solutions, Inc, analyses the use of such methods  
download pdf
Sarah Powell at Thomson Scientific argues that organisations must be familiar with the needs of a project before embarking on an eCTD transition plan, and must understand its potential impact on existing standards, processes, resources and technology in order to help avoid common mistakes.  
download pdf
bullet
ECG CORE LABS & CARDIAC SAFETY
Continuing an investigation into drug-induced vascular thrombosis, myocardial ischemia and infarction, Boaz Mendzelevski at Cardiac Safety Consultants Ltd, explains that due to increased regulatory and public attention, drug manufacturers can no longer ignore the risks involved  
download pdf
Dr Wolfgang Timmer of CRS examines the conduct of thorough QTc trials in practice from a Phase I CRO’s perspective, arguing that there should be a standard form in order to maintain equality, reduce the time to market and speed development from Phase I  
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

XenoGesis and Juniper Pharma Services strengthen alliance in early drug development services

XenoGesis and Juniper Pharma Services have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

Industry Events

Pharmapack Europe 2018

7-8 February 2018, Hall 7.1, Paris Expo, Porte de Versailles, Paris.

As Europe's dedicated Pharmaceutical Packaging and Drug Delivery event, Pharmapack is the industry's go-to place to kick-off the year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement